Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression
Keywords: β-thujaplicin; DEHP; Plasticizer; E-selectin; ICAM-1; VCAM-1; MMP-2; MMP-9;